About Our Team and Experience
Ingentium is led by a team of experts with decades of experience in the fields of biomedical research, informatics, and artificial intelligence. The team is comprised of professionals with diverse backgrounds in pharmaceutical and medical research, computer science, and business, bringing a wealth of knowledge and skills to the company. With a passion for innovation and a commitment to excellence, the Ingentium team works tirelessly to develop and maintain cutting-edge technology solutions for the healthcare and life sciences industries. They strive to provide the best possible service to their clients and to help them achieve their goals through the power of advanced analytics and data-driven insights.
Keith Elliston, PhD – Executive Chairman
Dr. Elliston is a seasoned entrepreneur and a leader in the biomedical field. He is the co-founder and Executive Director of the i2b2 tranSMART Foundation, a non-profit organization focused on realizing the promise of precision medicine through open-source and open-data. He is also the founder and CEO of several biotechnology companies in the areas of biomedical computing, digital health and artificial intelligence. He brings over 15 years of experience in the pharmaceutical industry, where he built and ran bioinformatics and genomics efforts. Dr. Elliston has a track record of success in biotechnology as CSO, CEO, and Executive Chairman for more than a half-dozen companies. He has a strong sense of social responsibility, in 2011 he decided to give back, and spent 2 years building the systems biology efforts for Huntington’s Disease at CHDI, a non-profit virtual pharma focused on HD. He then co-Founded and served as CSO and CEO for the tranSMART Foundation, and Executive Director for its successor non-profit open-source effort, the i2b2 tranSMART Foundation, and is currently the CIO for the Open Source Pharma Foundation. Dr. Elliston is a proven leader with a track record of driving growth and innovation in the biomedical field.
Rudy Potenzone, PhD – Vice President and COO
Dr. Potenzone is a highly accomplished executive with a proven track record of delivering quality, profitable and customer-focused products. He excels in developing product roadmaps and corporate strategies, and has a wealth of experience in global life science, informatics, knowledge management, workflow systems and electronic laboratory notebooks. He is known for his ability to lead scientific and technology teams in the delivery of novel products and services. He has a deep understanding of organizational development and leadership, as well as executive team and board level communications. He is an expert in contract and vendor negotiations and management and is a respected speaker at pharma and IT industry forums. Dr. Potenzone has a unique ability to assess and implement acquisitions and is known for his excellent interpersonal skills with customers, employees and suppliers. With his strategic vision and leadership capabilities, Dr. Potenzone is poised to drive growth and success for any organization.
Richard Blevins, PhD – Vice President and CIO
Dr. Blevins is a seasoned executive with a wealth of experience in the pharmaceutical R&D industry. He is a leader and scientist with expertise in computational biology, informatics, chemistry, biochemistry, molecular biology, business development, and project/portfolio management. He has a strong leadership background, developed through departmental creation, staffing and administration in large pharma, small biotech, and academic environments. He is a visionary leader with a demonstrated ability to establish strong relationships with scientists and apply informatics techniques to biomedical research and drug discovery processes. Dr. Blevins is a strategic thinker with the ability to navigate complex challenges and drive innovation. He is a respected leader in the pharmaceutical R&D industry, and his skills and experience make him an asset to any organization.